Deep Track Capital, LP 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:41 am Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Deep Track Capital, LP | 0 0.000% |
-1,500,000 (Position Closed) |
Filing |
| 2022-02-14 08:57 am Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Deep Track Capital, LP | 1,500,000 6.130% |
233,116 (+18.40%) |
Filing |
| 2021-10-25 5:16 pm Purchase |
2021-10-21 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Deep Track Capital, LP | 1,266,884 5.180% |
1,266,884 (New Position) |
Filing |